fbpx
Connect with us
Organization

Specialists at the Moffitt Cancer Center work to treat patients, perform cancer research and educate the public about different types of cancer.

The nonprofit tackles multiple types of cancers fearlessly, first focusing on risk factors, detection and prevention. Patients can visit the Moffitt Cancer Center website and find a list of cancers and their symptoms and treatments. The goal is to make sure that patients are well-informed and comfortable as they fight against cancer. Patients are also treated by a compassionate team, who implement treatment plans that are unique to every individual. The Moffitt Cancer Center works tirelessly on research and provides a variety of the latest treatments – surgery, radiation therapy and immunotherapy.

Company Overview

Company Name

Moffitt Cancer Center

Year Established

1981

Number of Employees

Over 4500

Profile

Advancing personalized medicine and using predictive modeling to anticipate—and change—a tumor’s path. And exploring genomics, immunotherapy and more. Moffitt Cancer Center is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy, a promising approach to immunotherapy that uses a patient’s own immune cells to recognize and attack their tumors. Giving hope to patients with previously untreatable types of cancers.

Awards & Accolades

The Moffitt Cancer Center has received many awards and recognition, including being recognized by U.S. News & World Report as one of the best hospitals for treatment of cancer in the country, and one of the best in the state of Florida. A list of other rewards can be found in this link https://moffitt.org/careers/awards-recognition/

Core values/mission statement

The mission of H. Lee Moffitt Cancer Center & Research Institute is to contribute to the prevention and cure of cancer. Our vision is to transform cancer care through service, science and partnership.

Company Leadership

H. Lee Moffitt

Founder

H. Lee Moffitt recognized a need for a comprehensive cancer center in the state of Florida. In the late '70s, he suggested this idea to Dr. Hollis Boren and the then dean of the University of South Florida College of Medicine, and by the end of their lunch, both Dr. Boren and the dean agreed with Moffitt. Through community support and state funding, the center was able to open just a few years later, in 1983.

Alan List, MD

President & Chief Executive Officer

Dr. List is internationally recognized for his many contributions in the development of novel, more effective treatment strategies for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). His pioneering work led to the development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which went on to receive fast-track designation from the U.S. Food and Drug Administration and approval for the treatment of patients with MDS and multiple myeloma. This work transformed the natural history of MDS from a premalignant condition that progressed to malignancy requiring aggressive treatment to a condition managed in the outpatient setting with oral agents.

Executive Vice President, General Council

Mr. de la Parte is Executive Vice President and in-house General Counsel at H. Lee Moffitt Cancer Center and Research Institute. He joined Moffitt Cancer Center to establish its in-house General Counsel office in March 2007 after leaving de la Parte & Gilbert, P.A. as its managing partner. He received his Bachelor’s Degree in political science from Florida State University in 1983 and his Juris Doctor from Stetson University College of Law in 1985. While in private practice, Mr. de la Parte concentrated his practice in the general representation of clients in the health care industry and the representation of governmental and quasi-governmental agencies. He became Moffitt Cancer Center’s outside General Counsel in 1990.

John A. (Jack) Kolosky

Executive Vice President, Chief Operating Officer; President, Hospital Corporation

Mr. Kolosky is responsible for ensuring that high quality care is provided to its many patients and that the Cancer Center is compliant with regulatory agencies and accrediting bodies, continually monitoring Moffitt's service and delivery systems. Mr. Kolosky also has the role of corporate Executive Vice President/Chief Operating Officer, where he oversees Patient Care Services as well as corporate functions as Information Technology, Internal Audit and Facilities and Support Services.

More Organizations

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Please enter email address you want to share this article with